1. Home
  2. CENX vs SUPN Comparison

CENX vs SUPN Comparison

Compare CENX & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Aluminum Company

CENX

Century Aluminum Company

HOLD

Current Price

$36.03

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$51.53

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENX
SUPN
Founded
1995
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Aluminum
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
1996
2012

Fundamental Metrics

Financial Performance
Metric
CENX
SUPN
Price
$36.03
$51.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$33.00
$61.60
AVG Volume (30 Days)
1.9M
690.1K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.83
N/A
Revenue
$2,525,100,000.00
$681,539,000.00
Revenue This Year
$16.07
$8.32
Revenue Next Year
N/A
$23.36
P/E Ratio
$43.42
N/A
Revenue Growth
20.15
4.54
52 Week Low
$13.05
$29.16
52 Week High
$37.05
$57.65

Technical Indicators

Market Signals
Indicator
CENX
SUPN
Relative Strength Index (RSI) 71.87 68.51
Support Level $31.71 $45.36
Resistance Level $33.06 $47.26
Average True Range (ATR) 1.52 1.47
MACD 0.50 0.70
Stochastic Oscillator 86.85 92.77

Price Performance

Historical Comparison
CENX
SUPN

About CENX Century Aluminum Company

Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: